Search
for
Sort by
Research 151–180 of 293
- A systematic simulation-based meta-analytical framework for prediction of physiological biomarkers in alopecia
- Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives
- Diphencyprone Induced Vitiligo: A Case Report
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- Eating Disorders and Diabetes: Facing the Dual Challenge
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Breast Embryology, Anatomy, and Physiology
- Bitemporal Scalp Hair Loss: Differential Diagnosis of Nonscarring and Scarring Conditions.
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- A Retrospective Study on Alopecia Areata in Children: Clinical Characteristics and Treatment Choices
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Status of research on the development and regeneration of hair follicles
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives – A review
- Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis
- How Much Worse Will My Voiding Symptoms Get over Time?
- This Month in Clinical Urology
- Alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Organ Specificity in Autoimmune Diseases: Thyroid and Islet Autoimmunity in Alopecia Areata
- Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study